Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:50 pm Sale |
2024-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX |
Armistice Capital, LLC | 2,078,000 8.250% |
-322,000 (-13.42%) |
Filing History |
| 2025-02-06 3:10 pm Purchase |
2025-02-04 | 13D | Accelerate Diagnostics, Inc. AXDX |
Indaba Capital Management, L.P. | 2,751,762 9.900% |
149,921 (+5.76%) |
Filing History |
| 2025-01-07 4:22 pm Sale |
2024-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX |
GRIFFIN ASSET MANAGEMENT INC. | 1,003,581 4.000% |
-216,143 (-17.72%) |
Filing History |
| 2024-12-05 5:13 pm Sale |
2024-12-03 | 13D | Accelerate Diagnostics, Inc. AXDX |
SCHULER JACK W | 11,047,376 39.800% |
-187,369 (-1.67%) |
Filing History |
| 2024-11-14 3:24 pm Purchase |
2024-09-30 | 13G | Accelerate Diagnostics, Inc. AXDX |
Armistice Capital, LLC | 2,400,000 9.930% |
2,400,000 (New Position) |
Filing History |
| 2024-08-12 5:01 pm Purchase |
2024-08-08 | 13D | Accelerate Diagnostics, Inc. AXDX |
Indaba Capital Management, L.P. | 2,601,841 9.900% |
1,004,617 (+62.90%) |
Filing History |
| 2024-05-23 7:17 pm Purchase |
2024-01-19 | 13D | Accelerate Diagnostics, Inc. AXDX |
SCHULER JACK W | 11,234,745 45.400% |
11,234,745 (New Position) |
Filing History |
| 2024-03-05 3:59 pm Purchase |
2023-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX |
GRIFFIN ASSET MANAGEMENT INC. | 1,219,724 8.400% |
1,219,724 (New Position) |
Filing History |
| 2023-06-20 5:26 pm Purchase |
2023-06-09 | 13D | Accelerate Diagnostics, Inc. AXDX |
Indaba Capital Management, L.P. | 1,597,224 9.900% |
1,597,224 (New Position) |
Filing History |
| 2023-06-20 5:10 pm Purchase |
2023-06-09 | 13D | Accelerate Diagnostics, Inc. AXDX |
SCHULER JACK W | 5,801,221 40.600% |
3,775,126 (+186.33%) |
Filing History |
| 2023-06-08 1:58 pm Purchase |
2023-02-15 | 13D | Accelerate Diagnostics, Inc. AXDX |
SCHULER JACK W | 2,026,095 19.990% |
185,171 (+10.06%) |
Filing History |
| 2022-02-24 4:20 pm Sale |
2022-02-18 | 13G | Pacific Biosciences of California, Inc. PACB |
FEINBERG LARRY N | 3,257,503 4.970% |
-370,046 (-10.20%) |
Filing History |
| 2022-02-11 4:04 pm Sale |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
FEINBERG LARRY N | 3,627,549 5.530% |
-178,590 (-4.69%) |
Filing History |
| 2021-12-02 8:05 pm Purchase |
2021-11-29 | 13D | Accelerate Diagnostics, Inc. AXDX |
SCHULER JACK W | 1,840,924 26.400% |
122,228 (+7.11%) |
Filing History |
| 2021-10-05 4:12 pm Purchase |
2021-09-15 | 13D | Accelerate Diagnostics, Inc. AXDX |
SCHULER JACK W | 1,718,696 25.700% |
10,717 (+0.63%) |
Filing History |
| 2021-02-16 4:02 pm Sale |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
FEINBERG LARRY N | 3,806,139 6.670% |
-890,513 (-18.96%) |
Filing History |
| 2021-02-12 4:48 pm Sale |
2020-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX |
CREDIT SUISSE FIRST BOSTON | 176,539 3.100% |
-133,836 (-43.12%) |
Filing History |